United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -289,500 | -494,600 | 589,200 | 523,900 | 417,400 |
| Depreciation Amortization | 20,700 | 10,300 | 35,900 | 25,400 | 16,000 |
| Accounts receivable | -5,300 | 16,000 | 121,400 | 81,900 | 45,800 |
| Accounts payable and accrued liabilities | -3,000 | -27,700 | -11,000 | 21,900 | 39,900 |
| Other Working Capital | -189,500 | -179,000 | 124,400 | 156,100 | 104,800 |
| Other Operating Activity | -27,900 | 47,600 | -81,500 | -116,200 | -168,400 |
| Operating Cash Flow | $-494,500 | $-627,400 | $778,400 | $693,000 | $455,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -57,500 | -35,200 | -732,000 | -458,700 | -327,400 |
| PPE Investments | -45,400 | -25,100 | -184,400 | -132,600 | -91,100 |
| Net Acquisitions | N/A | N/A | -124,100 | -124,100 | N/A |
| Purchase Of Investment | N/A | N/A | -46,000 | -33,000 | N/A |
| Sale Of Investment | N/A | N/A | 265,900 | N/A | N/A |
| Investing Cash Flow | $-102,900 | $-60,300 | $-820,600 | $-748,400 | $-418,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 800,000 | 800,000 | 250,000 | 250,000 | 250,000 |
| Common Stock Issued | 12,100 | 11,000 | 19,500 | 19,400 | 17,000 |
| Common Stock Repurchased | -1,900 | -1,900 | N/A | N/A | N/A |
| Other Financing Activity | -700 | 0 | -263,200 | -263,200 | -263,200 |
| Financing Cash Flow | $809,500 | $809,100 | $6,300 | $6,200 | $3,800 |
| Exchange Rate Effect | N/A | N/A | N/A | 100 | N/A |
| Beginning Cash Position | 669,200 | 669,200 | 705,100 | 705,100 | 705,100 |
| End Cash Position | 881,300 | 790,600 | 669,200 | 656,000 | 745,900 |
| Net Cash Flow | $212,100 | $121,400 | $-35,900 | $-49,100 | $40,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -494,500 | -627,400 | 778,400 | 693,000 | 455,500 |
| Capital Expenditure | -45,400 | -25,100 | -184,400 | -132,600 | -91,100 |
| Free Cash Flow | -539,900 | -652,500 | 594,000 | 560,400 | 364,400 |